Julian P. Legg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Julian P. Legg has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Sebastian L. Johnston
National Heart and Lung Institute, Imperial College London London UK
3 shared publications Jill A. Warner
2 shared publicationsJohn O. Warner
2 shared publicationsC A Jones
Department of Child Health, University of Southampton, Southampton, UK
1 shared publicationImran R. Hussain
Infection, Inflammation and Repair Division, University of Southampton, Southampton; and Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College of Science Technology & Medicine, London, United Kingdom
1 shared publicationJ A Warner
Department of Child Health, University of Southampton, Southampton, UK
1 shared publication
Latest Publications
- 1 July 2005
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 24 (7) , 611-616
Frequency of Detection of Picornaviruses and Seven Other Respiratory Pathogens in Infants
Previous studies in which molecular-based techniques have been used to identify the causative pathogens of respiratory tract infection have investigated hospitalized children only. We report a prospective study designed to determine the frequency and clinical presentation of community-acquired respiratory illness in infancy associated with 8 common respiratory pathogens. Eighty-eight infants were monitored through their first winter. With each respiratory illness, infants were examined, and a nasal lavage specimen was collected. Individual reverse transcription-polymerase chain reactions were performed to detect infection with picornaviruses (rhinoviruses and enteroviruses), coronaviruses (serotypes OC43 and 229E), adenoviruses, parainfluenza viruses 1–3, influenza viruses (types A and B), respiratory syncytial virus (RSV), Chlamydia pneumoniae and Mycoplasma pneumoniae. Picornaviruses were the most frequently detected pathogen identified in 46% (56 of 123) of episodes, followed by RSV (27%), parainfluenza viruses (13%) and coronaviruses (9%). Dual pathogen infections were identified in 20% of episodes, predominantly caused by picornaviruses together with either RSV or parainfluenza viruses. RSV infection was significantly associated with a diagnosis of bronchiolitis. No other associations were found between pathogen and clinical diagnosis. Dual infection did not predispose infants to a more severe clinical course. Picornaviruses are the predominant cause of community-acquired respiratory tract infection in the first year of life. Large prospective community-based studies will be needed to fully evaluate the contribution of picornaviruses, both in isolation and in combination with other respiratory pathogens, to the various clinical syndromes of respiratory infection observed during infancy.
- 1 July 2005
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 24 (7) , 611-616
Frequency of Detection of Picornaviruses and Seven Other Respiratory Pathogens in Infants
Previous studies in which molecular-based techniques have been used to identify the causative pathogens of respiratory tract infection have investigated hospitalized children only. We report a prospective study designed to determine the frequency and clinical presentation of community-acquired respiratory illness in infancy associated with 8 common respiratory pathogens. Eighty-eight infants were monitored through their first winter. With each respiratory illness, infants were examined, and a nasal lavage specimen was collected. Individual reverse transcription-polymerase chain reactions were performed to detect infection with picornaviruses (rhinoviruses and enteroviruses), coronaviruses (serotypes OC43 and 229E), adenoviruses, parainfluenza viruses 1–3, influenza viruses (types A and B), respiratory syncytial virus (RSV), Chlamydia pneumoniae and Mycoplasma pneumoniae. Picornaviruses were the most frequently detected pathogen identified in 46% (56 of 123) of episodes, followed by RSV (27%), parainfluenza viruses (13%) and coronaviruses (9%). Dual pathogen infections were identified in 20% of episodes, predominantly caused by picornaviruses together with either RSV or parainfluenza viruses. RSV infection was significantly associated with a diagnosis of bronchiolitis. No other associations were found between pathogen and clinical diagnosis. Dual infection did not predispose infants to a more severe clinical course. Picornaviruses are the predominant cause of community-acquired respiratory tract infection in the first year of life. Large prospective community-based studies will be needed to fully evaluate the contribution of picornaviruses, both in isolation and in combination with other respiratory pathogens, to the various clinical syndromes of respiratory infection observed during infancy.
- 15 September 2003
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 168 (6) , 633-639
Type 1 and Type 2 Cytokine Imbalance in Acute Respiratory Syncytial Virus Bronchiolitis
We examined the in vivo immune response of infants to natural respiratory syncytial virus (RSV) infection through analysis of cytokine levels in nasal lavage fluid and stimulated peripheral blood mononuclear cells. Eighty-eight babies with at least one parent with atopy and asthma were prospectively studied through their first winter. Twenty-eight infants had an upper respiratory tract infection where RSV was detected, of whom nine developed signs of acute bronchiolitis. Nasal lavage specimens were assayed for interferon-γ, interleukin (IL)-4, IL-10, and IL-12 and the RSV load determined by quantitative polymerase chain reaction. Messenger RNA (mRNA) was extracted from stimulated peripheral blood mononuclear cells and interferon-γ, IL-4, IL-12, and IL-18 mRNA levels determined by polymerase chain reaction. Cytokine profiles were analyzed in relation to clinical outcome. The IL-4/interferon-γ ratio for infants with acute bronchiolitis was elevated in nasal lavage fluid on both Days 1–2 (p = 0.014) and Days 5–7 (p = 0.001) of the illness compared with infants with upper respiratory tract infection alone. Those with acute bronchiolitis demonstrated a higher IL-10/IL-12 ratio (p = 0.0015) on Days 1–2. IL-18 mRNA levels were reduced (p = 0.019) and the IL-4/interferon-γ ratio elevated (p = 0.01) in stimulated peripheral blood mononuclear cells from infants with acute bronchiolitis. There was no difference in initial RSV load. These data strongly implicate excess type 2 and/or deficient type 1 immune responses in the pathogenesis of RSV bronchiolitis.
- 15 September 2003
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 168 (6) , 633-639
Type 1 and Type 2 Cytokine Imbalance in Acute Respiratory Syncytial Virus Bronchiolitis
We examined the in vivo immune response of infants to natural respiratory syncytial virus (RSV) infection through analysis of cytokine levels in nasal lavage fluid and stimulated peripheral blood mononuclear cells. Eighty-eight babies with at least one parent with atopy and asthma were prospectively studied through their first winter. Twenty-eight infants had an upper respiratory tract infection where RSV was detected, of whom nine developed signs of acute bronchiolitis. Nasal lavage specimens were assayed for interferon-γ, interleukin (IL)-4, IL-10, and IL-12 and the RSV load determined by quantitative polymerase chain reaction. Messenger RNA (mRNA) was extracted from stimulated peripheral blood mononuclear cells and interferon-γ, IL-4, IL-12, and IL-18 mRNA levels determined by polymerase chain reaction. Cytokine profiles were analyzed in relation to clinical outcome. The IL-4/interferon-γ ratio for infants with acute bronchiolitis was elevated in nasal lavage fluid on both Days 1–2 (p = 0.014) and Days 5–7 (p = 0.001) of the illness compared with infants with upper respiratory tract infection alone. Those with acute bronchiolitis demonstrated a higher IL-10/IL-12 ratio (p = 0.0015) on Days 1–2. IL-18 mRNA levels were reduced (p = 0.019) and the IL-4/interferon-γ ratio elevated (p = 0.01) in stimulated peripheral blood mononuclear cells from infants with acute bronchiolitis. There was no difference in initial RSV load. These data strongly implicate excess type 2 and/or deficient type 1 immune responses in the pathogenesis of RSV bronchiolitis.
- 1 November 2002
- Published by Wolters Kluwer Health in Clinical Pulmonary Medicine
- Vol. 9 (6) , 306-314
Respiratory Syncytial Virus Infection: Determinants of Disease Severity
Respiratory syncytial virus (RSV) remains the leading cause of hospitalization in infancy and is increasingly recognized as an important pathogen in older adults and children. RSV infection is associated with a wide spectrum of clinical response, from mild upper respiratory tract infection to life-threatening bronchiolitis and pneumonia. Both viral and host factors seem to be important in determining the clinical response to RSV infection. Viral load, as assessed by quantitative culture of nasal specimens, has been shown to correlate with disease severity in some but not all studies. Similarly, the two major antigenic groups of RSV have been inconsistently associated with increased disease severity. Recent data have raised the possibility that genotypic differences between strains may affect RSV virulence and the pattern of clinical response to infection. Host factors possibly exacerbating RSV disease in infancy include small airways geometry and an atopic family history. Furthermore, the host immune response seems to play a pivotal role in determining the outcome of RSV infection. Many aspects of both the innate and adaptive immune response have been identified as important determinants of disease severity. Underlying cardiopulmonary and immunologic disease predispose to severe infection in all age groups, whereas older age per se seems to be associated with increased RSV-related morbidity and mortality. Additional comprehensive studies are needed to determine the relative importance of both viral and host factors in disease pathogenesis.
- 1 November 2002
- Published by Wolters Kluwer Health in Clinical Pulmonary Medicine
- Vol. 9 (6) , 306-314
Respiratory Syncytial Virus Infection: Determinants of Disease Severity
Respiratory syncytial virus (RSV) remains the leading cause of hospitalization in infancy and is increasingly recognized as an important pathogen in older adults and children. RSV infection is associated with a wide spectrum of clinical response, from mild upper respiratory tract infection to life-threatening bronchiolitis and pneumonia. Both viral and host factors seem to be important in determining the clinical response to RSV infection. Viral load, as assessed by quantitative culture of nasal specimens, has been shown to correlate with disease severity in some but not all studies. Similarly, the two major antigenic groups of RSV have been inconsistently associated with increased disease severity. Recent data have raised the possibility that genotypic differences between strains may affect RSV virulence and the pattern of clinical response to infection. Host factors possibly exacerbating RSV disease in infancy include small airways geometry and an atopic family history. Furthermore, the host immune response seems to play a pivotal role in determining the outcome of RSV infection. Many aspects of both the innate and adaptive immune response have been identified as important determinants of disease severity. Underlying cardiopulmonary and immunologic disease predispose to severe infection in all age groups, whereas older age per se seems to be associated with increased RSV-related morbidity and mortality. Additional comprehensive studies are needed to determine the relative importance of both viral and host factors in disease pathogenesis.
- Open Access
- 1 June 2002
- Published by BMJ in Archives of Disease in Childhood
- Vol. 86 (6) , 431-433
A hypothesis: antenatal sensitisation to respiratory syncytial virus in viral bronchiolitis
Aim: To investigate the possibility of antenatal sensitisation to respiratory syncytial virus (RSV). Methods: A total of 36 cord blood specimens were obtained from newborn infants; serum IgA was measured to exclude maternal blood contamination. Cord peripheral blood mononuclear cells were separated and cultured in the presence of either uninfected negative control cells or cells containing ultraviolet (UV) inactivated RSV. Proliferation was assessed by tritiated thymidine incorporation. Supernatant cytokine concentrations were measured using ELISA. Results: Significantly higher proliferative response rates to UV inactivated RSV were shown in those infants exposed in utero to the RSV epidemic after 22 weeks gestation. UV inactivated RSV stimulation induced significantly higher interferon γ production from specimens with a positive proliferative response (sensitised) than from those with a negative response (not sensitised). Conclusions: Antenatal sensitisation to RSV occurs in one third of infants exposed to an RSV epidemic at the appropriate time of gestation. This sensitisation is associated with increased interferon γ production, suggesting a type 1 memory response. We hypothesise that priming of fetal T cells to RSV results in a reduced severity of subsequent RSV disease in these individuals and that this will explain much of the clinical diversity of RSV disease.
- 1 June 2002
- Published by BMJ in Archives of Disease in Childhood
- Vol. 86 (6) , 431-433
Open AccessA hypothesis: antenatal sensitisation to respiratory syncytial virus in viral bronchiolitis
Aim: To investigate the possibility of antenatal sensitisation to respiratory syncytial virus (RSV). Methods: A total of 36 cord blood specimens were obtained from newborn infants; serum IgA was measured to exclude maternal blood contamination. Cord peripheral blood mononuclear cells were separated and cultured in the presence of either uninfected negative control cells or cells containing ultraviolet (UV) inactivated RSV. Proliferation was assessed by tritiated thymidine incorporation. Supernatant cytokine concentrations were measured using ELISA. Results: Significantly higher proliferative response rates to UV inactivated RSV were shown in those infants exposed in utero to the RSV epidemic after 22 weeks gestation. UV inactivated RSV stimulation induced significantly higher interferon γ production from specimens with a positive proliferative response (sensitised) than from those with a negative response (not sensitised). Conclusions: Antenatal sensitisation to RSV occurs in one third of infants exposed to an RSV epidemic at the appropriate time of gestation. This sensitisation is associated with increased interferon γ production, suggesting a type 1 memory response. We hypothesise that priming of fetal T cells to RSV results in a reduced severity of subsequent RSV disease in these individuals and that this will explain much of the clinical diversity of RSV disease.